Pharmacological prevention of fibrosis in dacryosurgery
Chronic inflammatory process in the lacrimal drainage system is the main etiological factor leading to dacryostenosis and consequent obliteration - partial and total nasolacrimal duct obstruction. Prevention of this process is an urgent problem in dacryology. Currently, there is very little research...
Saved in:
| Published in: | Vestnik oftal'mologii Vol. 140; no. 2. Vyp. 2; p. 180 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Journal Article |
| Language: | English Russian |
| Published: |
Russia (Federation)
2024
|
| Subjects: | |
| ISSN: | 0042-465X |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Chronic inflammatory process in the lacrimal drainage system is the main etiological factor leading to dacryostenosis and consequent obliteration - partial and total nasolacrimal duct obstruction. Prevention of this process is an urgent problem in dacryology. Currently, there is very little research on the development and use of conservative methods for treating dacryostenosis using anti-inflammatory, as well as anti-fibrotic drugs. In this regard, the main method of treating lacrimal drainage obstruction is dacryocystorhinostomy. However, the problem of recurrence after this operation has not been resolved. The causes of recurrence can be cicatricial healing of dacryocystorhinostomy ostium, canalicular obstruction, formation of granulations and synechiae in its area. Surgical methods of recurrence prevention are associated with possible complications, and there is conflicting data on the feasibility of their use. Based on this, the development of pharmacological methods for the prevention of fibrosis in dacryology is promising, among which the antitumor antibiotic Mitomycin C is the most studied. However, there are no specific scientifically substantiated recommendations for the use of this drug, and the data on its effectiveness vary. This has prompted researchers to look for and study alternative anti-fibrotic agents, such as antitumor drugs, glucocorticoids, hyaluronic acid, small molecule, biological, immunological and genetically engineered drugs, as well as nanoparticles. This review presents the current data on the efficacy and prospects of the use of these drugs in dacryology. |
|---|---|
| AbstractList | Chronic inflammatory process in the lacrimal drainage system is the main etiological factor leading to dacryostenosis and consequent obliteration - partial and total nasolacrimal duct obstruction. Prevention of this process is an urgent problem in dacryology. Currently, there is very little research on the development and use of conservative methods for treating dacryostenosis using anti-inflammatory, as well as anti-fibrotic drugs. In this regard, the main method of treating lacrimal drainage obstruction is dacryocystorhinostomy. However, the problem of recurrence after this operation has not been resolved. The causes of recurrence can be cicatricial healing of dacryocystorhinostomy ostium, canalicular obstruction, formation of granulations and synechiae in its area. Surgical methods of recurrence prevention are associated with possible complications, and there is conflicting data on the feasibility of their use. Based on this, the development of pharmacological methods for the prevention of fibrosis in dacryology is promising, among which the antitumor antibiotic Mitomycin C is the most studied. However, there are no specific scientifically substantiated recommendations for the use of this drug, and the data on its effectiveness vary. This has prompted researchers to look for and study alternative anti-fibrotic agents, such as antitumor drugs, glucocorticoids, hyaluronic acid, small molecule, biological, immunological and genetically engineered drugs, as well as nanoparticles. This review presents the current data on the efficacy and prospects of the use of these drugs in dacryology. Chronic inflammatory process in the lacrimal drainage system is the main etiological factor leading to dacryostenosis and consequent obliteration - partial and total nasolacrimal duct obstruction. Prevention of this process is an urgent problem in dacryology. Currently, there is very little research on the development and use of conservative methods for treating dacryostenosis using anti-inflammatory, as well as anti-fibrotic drugs. In this regard, the main method of treating lacrimal drainage obstruction is dacryocystorhinostomy. However, the problem of recurrence after this operation has not been resolved. The causes of recurrence can be cicatricial healing of dacryocystorhinostomy ostium, canalicular obstruction, formation of granulations and synechiae in its area. Surgical methods of recurrence prevention are associated with possible complications, and there is conflicting data on the feasibility of their use. Based on this, the development of pharmacological methods for the prevention of fibrosis in dacryology is promising, among which the antitumor antibiotic Mitomycin C is the most studied. However, there are no specific scientifically substantiated recommendations for the use of this drug, and the data on its effectiveness vary. This has prompted researchers to look for and study alternative anti-fibrotic agents, such as antitumor drugs, glucocorticoids, hyaluronic acid, small molecule, biological, immunological and genetically engineered drugs, as well as nanoparticles. This review presents the current data on the efficacy and prospects of the use of these drugs in dacryology.Chronic inflammatory process in the lacrimal drainage system is the main etiological factor leading to dacryostenosis and consequent obliteration - partial and total nasolacrimal duct obstruction. Prevention of this process is an urgent problem in dacryology. Currently, there is very little research on the development and use of conservative methods for treating dacryostenosis using anti-inflammatory, as well as anti-fibrotic drugs. In this regard, the main method of treating lacrimal drainage obstruction is dacryocystorhinostomy. However, the problem of recurrence after this operation has not been resolved. The causes of recurrence can be cicatricial healing of dacryocystorhinostomy ostium, canalicular obstruction, formation of granulations and synechiae in its area. Surgical methods of recurrence prevention are associated with possible complications, and there is conflicting data on the feasibility of their use. Based on this, the development of pharmacological methods for the prevention of fibrosis in dacryology is promising, among which the antitumor antibiotic Mitomycin C is the most studied. However, there are no specific scientifically substantiated recommendations for the use of this drug, and the data on its effectiveness vary. This has prompted researchers to look for and study alternative anti-fibrotic agents, such as antitumor drugs, glucocorticoids, hyaluronic acid, small molecule, biological, immunological and genetically engineered drugs, as well as nanoparticles. This review presents the current data on the efficacy and prospects of the use of these drugs in dacryology. |
| Author | Murakhovskaya, Yu K Fokina, N D Smirnova, N S Avagyan, A S Krakhovetskiy, N N Atkova, E L Kulish, K K |
| Author_xml | – sequence: 1 givenname: E L orcidid: 0000-0001-9875-6217 surname: Atkova fullname: Atkova, E L organization: Krasnov Research Institute of Eye Diseases, Moscow, Russia – sequence: 2 givenname: N N orcidid: 0000-0002-3247-8418 surname: Krakhovetskiy fullname: Krakhovetskiy, N N organization: Krasnov Research Institute of Eye Diseases, Moscow, Russia – sequence: 3 givenname: N D orcidid: 0000-0003-2450-0395 surname: Fokina fullname: Fokina, N D organization: I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia – sequence: 4 givenname: Yu K orcidid: 0000-0002-1251-6405 surname: Murakhovskaya fullname: Murakhovskaya, Yu K organization: I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia – sequence: 5 givenname: K K orcidid: 0000-0001-7412-0994 surname: Kulish fullname: Kulish, K K organization: Krasnov Research Institute of Eye Diseases, Moscow, Russia – sequence: 6 givenname: A S orcidid: 0000-0002-5642-7092 surname: Avagyan fullname: Avagyan, A S organization: Krasnov Research Institute of Eye Diseases, Moscow, Russia – sequence: 7 givenname: N S orcidid: 0000-0002-8054-3691 surname: Smirnova fullname: Smirnova, N S organization: I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38739149$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1j71OwzAURj0U0VL6CKCMLIFrxz_xiCooSJVgAIktsp3rYpTEwW6Q-vZUokxnOeeTvgsyG-KAhFxRuKWKUnkX_d50vWHAOOUAjNEaZmQBwFnJpfiYk1XOXwBAuZBUyXMyr2pVacr1gqjXT5N642IXd8GZrhgT_uCwD3Eooi98sCnmkIswFK1x6RDzlHaYDpfkzJsu4-rEJXl_fHhbP5Xbl83z-n5bOgpMlwy8bzlaJVumtUVnZcV0660Xoq25kjUidwqFdhUYWXvLEISmFpAhPUZLcvO3O6b4PWHeN33IDrvODBin3FQgOK-oUOqoXp_UyfbYNmMKvUmH5v8s-wX1QlnC |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.17116/oftalma2024140022180 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| DocumentTitleAlternate | Medikamentoznaya profilaktika fibrotizatsii v dakriokhirurgii |
| ExternalDocumentID | 38739149 |
| Genre | Journal Article English Abstract Review |
| GroupedDBID | .GJ 53G ALMA_UNASSIGNED_HOLDINGS CGR CUY CVF ECM EIF F5P NPM VCL VIT VME 7X8 |
| ID | FETCH-LOGICAL-c1029-20ffd4eb76d299becb6329dfbf55d84768ee4c7e59c30a68fb2e0591b0e2e16d2 |
| IEDL.DBID | 7X8 |
| ISSN | 0042-465X |
| IngestDate | Fri Jul 11 12:29:56 EDT 2025 Thu Apr 03 07:05:34 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2. Vyp. 2 |
| Keywords | recurrence antifibrotic therapy obstruction of anastomosis nasal ostium failed DCR fibrosis Mitomycin C dacryocystorhinostomy |
| Language | English Russian |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c1029-20ffd4eb76d299becb6329dfbf55d84768ee4c7e59c30a68fb2e0591b0e2e16d2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-5642-7092 0000-0001-9875-6217 0000-0002-1251-6405 0000-0002-8054-3691 0000-0003-2450-0395 0000-0001-7412-0994 0000-0002-3247-8418 |
| PMID | 38739149 |
| PQID | 3054431577 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3054431577 pubmed_primary_38739149 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-00-00 |
| PublicationDateYYYYMMDD | 2024-01-01 |
| PublicationDate_xml | – year: 2024 text: 2024-00-00 |
| PublicationDecade | 2020 |
| PublicationPlace | Russia (Federation) |
| PublicationPlace_xml | – name: Russia (Federation) |
| PublicationTitle | Vestnik oftal'mologii |
| PublicationTitleAlternate | Vestn Oftalmol |
| PublicationYear | 2024 |
| SSID | ssj0001456176 |
| Score | 2.263857 |
| SecondaryResourceType | review_article |
| Snippet | Chronic inflammatory process in the lacrimal drainage system is the main etiological factor leading to dacryostenosis and consequent obliteration - partial and... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 180 |
| SubjectTerms | Antifibrotic Agents Dacryocystorhinostomy - adverse effects Dacryocystorhinostomy - methods Fibrosis - prevention & control Humans Lacrimal Duct Obstruction - etiology Lacrimal Duct Obstruction - prevention & control Lacrimal Duct Obstruction - therapy Postoperative Complications - etiology Postoperative Complications - prevention & control |
| Title | Pharmacological prevention of fibrosis in dacryosurgery |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38739149 https://www.proquest.com/docview/3054431577 |
| Volume | 140 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA7qevDiA1_riwhei0nz7ElEXDzosgeV3kqbByxos25dwX_vpO2yJ0HwkltCmJnMzDeZB0JXptSUcQ9I1UsAKBaeonaKJDoTRDrFNW3jHa-PajzWeZ5N-oBb06dVLnViq6htMDFGfg1yycHYCaVuZh9JnBoVf1f7ERrraMDAlYkpXSrXqxhL9A7a-XJtFQqXIu-LeBSl8hr0XPn2XgL85wAzwJhRTX53NFuDM9r571V30XbvauLbTjb20Np8sY_UZNWrOvIHz_oeTqHGwWMP6Dk00wZPa2xLM_8OTVc3fYBeRvfPdw9JPzwhMTSmtKTEe8tdpaQFiwOcqiRLM-srL4QFkyS1c9woJzLDSCm1r1IHrhatiEsdhU2HaKMOtTtGGA4wkhHNjZC8Mgb0Y-qZT40GMVSKDdHlkg4FCGf8cShrFxZNsaLEEB11xCxmXReNgmnFMsBnJ3_YfYq2Ipe60McZGnh4mu4cbZqvz2kzv2i5Dut48vQDLZa2mw |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacological+prevention+of+fibrosis+in+dacryosurgery&rft.jtitle=Vestnik+oftal%27mologii&rft.au=Atkova%2C+E+L&rft.au=Krakhovetskiy%2C+N+N&rft.au=Fokina%2C+N+D&rft.au=Murakhovskaya%2C+Yu+K&rft.date=2024-01-01&rft.issn=0042-465X&rft.volume=140&rft.issue=2.+Vyp.+2&rft.spage=180&rft_id=info:doi/10.17116%2Foftalma2024140022180&rft_id=info%3Apmid%2F38739149&rft_id=info%3Apmid%2F38739149&rft.externalDocID=38739149 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0042-465X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0042-465X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0042-465X&client=summon |